Full Breakdown
Ethics Dispute Over HHS Secretary Robert F. Kennedy Jr.’s Conflict-of-Interest Agreement
By Drooid · · How we work
Core Event: Democrats Demand Explanation of Ethics-Agreement Change
Congressional Democrats have written to Health and Human Services Secretary Robert F. Kennedy Jr. after learning that he altered a previously disclosed ethics agreement. The senators allege that, instead of transferring his 10 % contingency-fee interest in Gardasil litigation to his son as promised, Kennedy reassigned the interest to his former law firm, Wisner Baum. They say the change was not reported to Congress or HHS ethics officials and request clarification of any ongoing compensation arrangement with the firm.
Background & Context
During his confirmation process in early 2025, Kennedy filed an ethics disclosure stating he would retain a 10 % contingency fee on cases he referred to Wisner Baum and would transfer any proceeds to his adult son. After the confirmation hearings, he quietly amended the disclosure, assigning the fee interest directly to Wisner Baum, a firm that also employs his son Conor Kennedy. The senators’ letter notes that the amendment was not reflected in any updated filing.
Data & Statistics
- The original January 2025 disclosure listed a 10 % contingency-fee interest in lawsuits against Merck over the HPV vaccine Gardasil.
- Kennedy’s 2024 earnings from that arrangement were reported at over $850,000.
Official Statements & Responses
HHS press secretary Emily G. Hilliard affirmed the department’s view of compliance:
“These troubling findings call into question the veracity of your public ethics commitments, your transparency with Congress and the public, and potentially, your compliance with federal ethics disclosure laws and regulations.” — Emily G. Hilliard, HHS press secretary
“He retained no financial interest in those fees, and HHS ethics officials confirmed his compliance to the relevant congressional committees,” — Hillard
Verbatim Quotes
- “These troubling findings call into question the veracity of your public ethics commitments, your transparency with Congress and the public, and potentially, your compliance with federal ethics disclosure laws and regulations.” — Emily G. Hilliard, HHS press secretary
- “He retained no financial interest in those fees, and HHS ethics officials confirmed his compliance to the relevant congressional committees,” — Emily Hilliard, HHS press secretary